Form 4: Guardian Pharmacy Services Executive Sells Over 400,000 Shares in Pre-Planned Transactions

Kendall Forbes, Executive Vice President of Sales & Operations at Guardian Pharmacy Services, Inc., reported the sale of 415,049 shares of Class A Common Stock for approximately $8.37 million through pre-arranged transactions.

Summary

• Kendall Forbes, Executive Vice President, Sales & Operations of Guardian Pharmacy Services, Inc. (GRDN), reported the sale of company stock.
• On May 27, 2025, Forbes sold 350,058 shares of Class A Common Stock at a price of $20.16 per share.
• On May 28, 2025, an additional 64,991 shares of Class A Common Stock were sold at the same price of $20.16 per share.
• The total number of shares sold across both transactions is 415,049.
• The total proceeds from these sales amount to approximately $8,369,783.84.
• These sales were conducted pursuant to an Underwriting Agreement dated May 22, 2025, and are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following these transactions, Kendall Forbes beneficially owns 203,906 shares of Class A Common Stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a large insider sale can sometimes be viewed negatively, the explicit mention of it being pursuant to a Rule 10b5-1 plan indicates a pre-planned, often routine, liquidity or diversification event, rather than a reaction to adverse company news.

Positives

• The sales were conducted under a Rule 10b5-1(c) plan, indicating a pre-planned transaction for diversification or liquidity rather than a reaction to recent company performance, which can reduce negative market perception.

Negatives

• The significant volume of shares sold (415,049 shares) by a key executive could be perceived by some investors as a reduction in insider alignment with shareholder interests, despite being pre-planned.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The document includes the title 'Executive Vice President, Sales & Operations' for Kendall Forbes and is signed by Douglas Towns, Attorney-in-Fact, on behalf of the reporting person.

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends within the pharmacy services sector.

Stakeholder Impact

• Shareholders may observe the reduction in direct ownership by a key executive, which could influence their perception of insider confidence, although the pre-planned nature of the sale mitigates some concerns.

Key Dates

Keywords

Guardian Pharmacy Services, GRDN, Kendall Forbes, Insider Trading, SEC Form 4, Stock Sale, Executive Stock Sale, Class A Common Stock, Rule 10b5-1 Plan, Beneficial Ownership